Your browser doesn't support javascript.
loading
Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers.
Ashare, Rebecca L; Worster, Brooke; Nugent, Shannon M; Smith, Danielle M; Morasco, Benjamin J; Leader, Amy E; Case, Amy A; Meghani, Salimah H.
Afiliación
  • Ashare RL; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA.
  • Worster B; Department of Psychology, University at Buffalo, Buffalo, NY, USA.
  • Nugent SM; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.
  • Smith DM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Morasco BJ; Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
  • Leader AE; Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Case AA; Department of Psychiatry, Oregon Health & Science University, Portland, OR, USA.
  • Meghani SH; Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.
J Natl Cancer Inst Monogr ; 2024(66): 267-274, 2024 Aug 15.
Article en En | MEDLINE | ID: mdl-39108237
ABSTRACT
Prescription opioids are used for managing pain in persons with cancer, however, there are socioeconomic and racial disparities in medication access. Cannabis is increasingly used for cancer symptom management and as an opioid alternative. Limited data are available about patterns of opioid and cannabis use among patients with cancer. We used survey data from 4 National Cancer Institute-designated cancer centers in 3 states (n = 1220) to assess perceptions, use of cannabis and opioids for pain, their substitution, and racial and ethnic differences in each outcome. Compared with White patients, Black patients were less likely to use opioids for pain (odds ratio [OR] = 0.66; P = .035) and more likely to report that cannabis was more effective than opioids (OR = 2.46; P = .03). Race effects were mitigated (P > .05) after controlling for socioeconomic factors. Further research is needed to understand cannabis and opioid use patterns and how overlapping social determinants of health create a disadvantage in cancer symptom management for Black patients.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Marihuana Medicinal / Dolor en Cáncer / Analgésicos Opioides / Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Natl Cancer Inst Monogr Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Marihuana Medicinal / Dolor en Cáncer / Analgésicos Opioides / Neoplasias Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: J Natl Cancer Inst Monogr Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos